The revolutionary GLP-1 class of weight loss drugs are racking up blockbuster sales at a pace rarely seen in the pharmaceutical industry. But the pharma industry’s gain is the food industry’s loss. Read more...
Site référencé: Quartz
weight loss, morgan stanley, anti obesity medication, health medical pharma, glp 1 receptor agonists, ozempic, glucagon like peptide 1, peptide therapeutics, glp 1, smithfield foods, sc johnson, semaglutide, obesity, wegovy, novo nordisk, peptide hormones, anti diabetic drugs, shane smith, social issues, addiction
Quartz
The Dow surges 1,100 points and the Nasdaq soars as the U.S. and China call a trade war truce
12/05/2025
10 cities where electric bills will spike the most this summer
12/05/2025
Apple's brutal year keeps getting worse
12/05/2025
Walmart, Cisco, Alibaba, Petrobras : Stocks to watch this week
11/05/2025
The case against Google, Nvidia's chip win, and Mark Zuckerberg's AI friends : Tech news roundup
10/05/2025
Trump makes a deal, Bill Gates on Elon Musk's DOGE, and an airport melts down : Business news roundup
10/05/2025
